The stock of Creative Medical Technology Holdings Inc (CELZ) has gone up by 13.64% for the week, with a 23.76% rise in the past month and a -17.49% drop in the past quarter. The volatility ratio for the week is 5.91%, and the volatility levels for the past 30 days are 4.44% for CELZ. The simple moving average for the last 20 days is 13.90% for CELZ stock, with a simple moving average of -14.74% for the last 200 days.
Is It Worth Investing in Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Right Now?
The 36-month beta value for CELZ is also noteworthy at 4.90. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CELZ is 2.53M, and at present, short sellers hold a 0.86% of that float. The average trading volume of CELZ on June 20, 2025 was 76.18K shares.
CELZ) stock’s latest price update
Creative Medical Technology Holdings Inc (NASDAQ: CELZ)’s stock price has increased by 11.61 compared to its previous closing price of 2.24. However, the company has seen a 13.64% increase in its stock price over the last five trading sessions. zacks.com reported 2025-03-25 that Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
CELZ Trading at 20.00% from the 50-Day Moving Average
After a stumble in the market that brought CELZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.77% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CELZ starting from Finger Michael H., who sale 750 shares at the price of $5.75 back on Feb 19 ’25. After this action, Finger Michael H. now owns 351 shares of Creative Medical Technology Holdings Inc, valued at $4,312 using the latest closing price.
Finger Michael H., the Director of Creative Medical Technology Holdings Inc, sale 750 shares at $5.00 during a trade that took place back on Feb 18 ’25, which means that Finger Michael H. is holding 1,101 shares at $3,750 based on the most recent closing price.
Stock Fundamentals for CELZ
Current profitability levels for the company are sitting at:
- -446.47 for the present operating margin
- -1.49 for the gross margin
The net margin for Creative Medical Technology Holdings Inc stands at -435.0. The total capital return value is set at -0.78. Equity return is now at value -70.45, with -67.79 for asset returns.
Currently, EBITDA for the company is -5.63 million with net debt to EBITDA at 1.25. When we switch over and look at the enterprise to sales, we see a ratio of -88.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 27.39.
Conclusion
In summary, Creative Medical Technology Holdings Inc (CELZ) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
